✦ LIBER ✦

3506 ORAL Axitinib (AG-013736) and gemcitabine vs gemcitabine in advanced pancreatic cancer: a randomised phase II study

✍ Scribed by J. Spano; C. Chodkiewicz; J. Maurel; R. Wong; H.S. Wasan; C. Barone; K.F. Liau; Y. Pithavala; P.W. Bycott; O. Rixe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of axitinib (AG-013736) in

✍ Jean-Philippe Spano, Malcolm J. Moore, Yazdi K. Pithavala, Alejandro D. Ricart, 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 356 KB

Efficacy of gemcitabine plus axitinib co

✍ Jean-Philippe Spano; Catherine Chodkiewicz; Joan Maurel; Ralph Wong; Harpreet Wa 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 191 KB

Axitinib plus gemcitabine versus placebo

✍ Hedy L Kindler; Tatsuya Ioka; Dirk J Richel; Jaafar Bennouna; Richard Létourneau 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 226 KB

6502 A double-blinded, placebo-controlle

✍ Kindler, H.L.; Ioka, T.; Richel, D.J.; Bennouna, J.; Létourneau, R.; Okusaka, T. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

5507 ORAL A phase 2 study of axitinib (A

✍ Cohen, E.; Vokes, E.E.; Rosen, L.S.; Kies, M.S.; Forastiere, A.A.; Worden, F.P.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Phase II study of gemcitabine in patient

✍ Camichael, J.; Fink, U.; Russell, R.C.G.; Spittie, M.F.; Harris, A.; Spiessi, G. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 163 KB